High sensitivity troponin T (hsTnT) is a strong predictor of adverse outcome during SARS-CoV-2 infection. However, its determinants remain partially unknown. We aimed to assess the relationship between severity of inflammatory response/coagulation abnormalities and hsTnT in Coronavirus Disease 2019 (COVID-19).
View Article and Find Full Text PDFObjective: To explore whether at-admission hyperglycemia is associated with worse outcomes in patients hospitalized for coronavirus disease 2019 (COVID-19).
Research Design And Methods: Hospitalized COVID-19 patients ( = 271) were subdivided based on at-admission glycemic status: ) glucose levels <7.78 mmol/L (NG) ( = 149 [55.